ArsenalBio

Arsenal Biosciences, Inc. (ArsenalBio)

This deep-tech company develops programmable T cell therapies for patients with solid tumours and autoimmune diseases.

Modulari-T Biosciences

This company develops modular immune receptors and delivery vehicles to create cell and gene therapies for patients with cancer and autoimmune diseases.

Autolus Therapeutics

This company develops programmed T-cell therapies for patients with cancer and autoimmune diseases.

Arcellx

This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.

Orca Bio

This company develops high-precision allogeneic cell therapies to treat patients with blood cancers and autoimmune diseases by replacing diseased immune systems with donor cells.

Artiva Biotherapeutics

The company develops allogeneic natural killer cell therapies for patients with autoimmune diseases and cancer.

3T Biosciences

The company develops T-cell receptor therapeutics and target identification technologies for oncology patients to treat solid tumours.

Appia Bio

This company develops engineered allogeneic cell therapies from hematopoietic stem cells for cancer patients.